全球鞘内泵市场规模、份额、趋势和成长分析报告（2026-2034年）

预计到 2034 年，脊髓内泵市场规模将从 2025 年的 4.2299 亿美元成长至 7.098 亿美元，2026 年至 2034 年的复合年增长率为 5.92%。

鞘内帮浦可将药物直接输送至脑脊髓液，作为一种标靶给药方案，在治疗慢性疼痛和痉挛方面正日益受到关注。推动这一增长的因素包括：临床上需要减少全身阿片类药物暴露，同时维持有效的镇痛效果；以及可程式设计控制器和长寿命电池等设备的改进。慢性疼痛疾病盛行率的不断上升、适应症的扩大（包括癌症疼痛）以及对神经调控疗法日益增长的需求，都在推动市场稳步扩张，并促使人们投资研发新一代的鞘内泵系统。

关键市场驱动因素包括临床指南的转变，建议局部用药治疗难治性疼痛；强有力的证据表明局部用药可改善生活品质；以及医保报销计划的扩大，这些计划认可了局部用药相比全身治疗的长期成本优势。诸如兼容MRI的泵、远端编程和改进的感染控制能力等技术进步正在降低临床应用障碍。然而，在外科基础设施有限的地区，移植手术的复杂性、成本考量以及治疗维持所需的专业设施等因素限制了市场扩张的加速。

未来前景乐观。随着製造商专注于安全性、远端监测和简化更换通讯协定以减少患者就医次数，预计将保持温和但稳定的复合年增长率。拓展新兴市场将取决于培训、报销和医院投资。与疼痛管理网络建立合作关係、创建真实世界数据 (RWE) 以及商品搭售服务（包括器械、植入和后续护理）将是扩大应用范围和改善患者就医体验的关键策略。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球鞘内帮浦市场：依类型划分

• 市场分析、洞察与预测
• Baclofen
• Bupivacaine
• 可乐定
• 氢可酮
• 地可诺胜肽
• 其他的

第五章 全球鞘内帮浦市场：依应用划分

• 市场分析、洞察与预测
• 痉挛
• 疼痛

第六章 全球鞘内帮浦市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Medtronic Plc
  • Codman & Shurtleff（A Johnson & Johnson Company）
  • Medallion Therapeutics
  • Arrow International Inc
  • Tricumed GmbH
  • Smiths Medical
  • Teleflex Incorporated
  • Flowonix Medical
  • Baxter International Inc
  • Durect Corporation

The Intrathecal Pumps Market size is expected to reach USD 709.80 Million in 2034 from USD 422.99 Million (2025) growing at a CAGR of 5.92% during 2026-2034.

Intrathecal pumps which deliver medication directly to the cerebrospinal fluid-are gaining traction as targeted drug-delivery solutions for chronic pain and spasticity. Growth stems from the clinical need to reduce systemic opioid exposure while maintaining effective analgesia, and from device improvements such as programmable controllers and longer battery life. Increasing prevalence of chronic pain conditions, expanding indications (including cancer pain), and rising demand for neuromodulation therapies are driving steady market expansion and investment in next-generation pump systems.

Key market drivers include shifting clinical guidelines favoring localized delivery for refractory pain, stronger evidence supporting quality-of-life gains, and reimbursement frameworks that increasingly recognize long-term cost savings versus systemic therapies. Technological advances-MRI-safe pumps, remote programming, and improved infection-control features-are lowering clinical barriers. Nevertheless, implantation complexity, cost considerations, and the need for specialized centers to manage therapy maintenance temper acceleration in regions with limited surgical infrastructure.

Future prospects are positive: expect modest but steady CAGR as manufacturers focus on safety, remote monitoring, and simplified refill protocols that reduce clinic visits. Expansion into emerging markets will depend on training, reimbursement, and hospital investment. Collaboration with pain-management networks, real-world evidence generation, and bundling of services (device, implant, follow-up care) will be key strategies to broaden adoption and improve patient access.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Baclofen
• Bupivacaine
• Clonidine
• Morphine
• Ziconotide
• Others

By Application

• Spasticity
• Pain

COMPANIES PROFILED

• Medtronic plc, Codman Shurtleff a Johnson Johnson company, Medallion Therapeutics, Arrow International Inc, Tricumed GmbH, Smiths Medical, Teleflex Incorporated, Flowonix Medical, Baxter International Inc, Durect Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL INTRATHECAL PUMPS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Baclofen Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Bupivacaine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Clonidine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Morphine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Ziconotide Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INTRATHECAL PUMPS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Spasticity Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pain Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INTRATHECAL PUMPS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Type
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Type
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Type
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Type
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Type
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL INTRATHECAL PUMPS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Medtronic Plc
  • 8.2.2 Codman & Shurtleff (A Johnson & Johnson Company)
  • 8.2.3 Medallion Therapeutics
  • 8.2.4 Arrow International Inc
  • 8.2.5 Tricumed GmbH
  • 8.2.6 Smiths Medical
  • 8.2.7 Teleflex Incorporated
  • 8.2.8 Flowonix Medical
  • 8.2.9 Baxter International Inc
  • 8.2.10 Durect Corporation